Today
Confidence
61%
High risk
BUY
$1.25–$1.28
TARGET
$1.95
STOP
$1.12
R:R
4.53 : 1
EXPECTED MOVE
+$0.68
HOLDING
7–13d
CATALYST
Conference abstract · 11 days
If you buy…
100 shares
≈ +$68
500 shares
≈ +$340
1,000 shares
≈ +$680
Why now
  • Bullish MACD momentum
  • Above all key moving averages (golden cross)
  • Institutional volume 3.2× normal
  • Conference abstract — 11 days
  • RSI in bullish momentum zone
Chance target hit
88%
Historical success
81%
Avg move
+$1.00
Avg hold
10d
Bull vs bear breakdown
Bull case

Conference abstract release historically moves shares >50%.

Bear case

Low coverage; thin liquidity intra-day.

Key risks

Single-trial concentration.

Setup

Breakout retest of $1.20 prior resistance.

Company snapshot

Clinical-stage biotech focused on breast cancer therapeutics.

Market cap
$155M
Float
121M
Avg volume
1.3M
Debt
Low
Position size calculator

Position Size Calculator

Shares
1,666
Capital Required
$2115.82
Max Loss
-$250.00
Profit @ T1
+$366.52
Profit @ T2
+$1132.88
Profit @ T3
+$2149.14